TikTok as a Platform for Patient Education and Health Information in Rare Genetic Diseases: Cross-Sectional Study
JMIR Formative Research · 2026
DOI: 10.2196/79978 ↗At a glance
Querschnittstudie in JMIR Formative Research, 2026. Written by Jackson Montgomery Wahman and 2 co-authors. Institution: College of Osteopathic Medicine, Sam Houston State University, Conroe, TX, United States. Major MEDLINE topics: Patient Education as Topic, Rare Diseases, Social Media. Cited 2 times so far (Crossref); 29 references. The full text is freely available in PubMed Central.
Abstract (original language)
Background
Rare genetic diseases pose significant diagnostic and therapeutic challenges, often leading to delayed diagnoses, misinformation, and patient isolation. Social media platforms have emerged as prominent spaces for health information dissemination and community building among patients with rare diseases.
Objective
This study aimed to evaluate the role of TikTok videos in patient education, community engagement, and information quality related to 5 rare genetic conditions: Ehlers-Danlos syndrome, Marfan syndrome, cystic fibrosis, Wilson disease, and Gaucher disease.
Methods
A cross-sectional analysis was conducted on 184 TikTok videos identified via disease-specific hashtags. Included videos were 15 seconds to 4 minutes long and directly discussed the target diseases. Advertisements, promotional content, and product marketing were excluded. Videos were categorized by creator type: physicians, medical professionals, patients, influencers, nonprofit organizations, and others. Content quality was assessed using the Global Quality Scale (GQS) and a modified DISCERN tool (mDISCERN). Engagement metrics (views, likes, and shares) were recorded. Kruskal-Wallis and chi-square tests evaluated differences across creator categories.
Results
Of the 184 TikTok videos, 88 (47.8%) were created by patients or family members; 31 (16.8%) by influencers, 24 (13.0%) by physicians, 17 (9.2%) by nonprofit organizations, 15 (8.2%) by general users, and 9 (4.9%) by others. Collectively, the videos amassed more than 123 million views. Influencer-generated content accounted for the highest cumulative view count, totaling approximately 60.9 million views. Content produced by medical professionals and physicians demonstrated higher information quality, with mean GQS scores of 3.89 (SD 0.66) and 3.62 (SD 0.71) and mDISCERN scores of 3.11 (SD 0.58) and 3.21 (SD 0.65), respectively. In contrast, videos by influencers and patients exhibited lower quality scores (influencers: GQS mean 1.48, SD 0.60; mDISCERN mean 1.42, SD 0.55; patients: GQS mean 1.57, SD 0.58; mDISCERN mean 1.38, SD 0.52). For Ehlers-Danlos syndrome (n=40 videos, 21.7%), Wilson disease (n=40 videos, 21.7%), and cystic fibrosis (n=34 videos, 18.5%), significant differences in quality scores among creator types were observed ( P
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- College of Osteopathic Medicine, Sam Houston State University, Conroe, TX, United States.
- Department of Physiology and Pharmacology, College of Osteopathic Medicine, Sam Houston State University, 925 City Central Ave, Conroe, TX, United States, 1 936-202-5221.
ORCID profiles: Jackson Montgomery Wahman, Rhoda Mariam Hijazi, Hosam Gharib Abdelhady
Cite
APA
Wahman, J. M., Hijazi, R. M., & Abdelhady, H. G. (2026). TikTok as a Platform for Patient Education and Health Information in Rare Genetic Diseases: Cross-Sectional Study. JMIR Formative Research. https://doi.org/10.2196/79978
Vancouver
Wahman JM, Hijazi RM, Abdelhady HG. TikTok as a Platform for Patient Education and Health Information in Rare Genetic Diseases: Cross-Sectional Study. JMIR Formative Research. 2026. doi:10.2196/79978
BibTeX
@article{Wahman2026,
author = {Wahman, Jackson Montgomery and Hijazi, Rhoda Mariam and Abdelhady, Hosam Gharib},
title = {TikTok as a Platform for Patient Education and Health Information in Rare Genetic Diseases: Cross-Sectional Study},
journal = {JMIR Formative Research},
year = {2026},
doi = {10.2196/79978}
}
EUVIMED